Für die internationalen PhD-Programme "Metabolic and Cardiovascular Disease (DK-MCD)", "Molecular Medicine (MolMed)" und im Spezialforschungsbereich (SFB) "Lipid Hydrolysis" können sich PhD-Studenten bis 15. September 2019 bewerben. Die Projekte starten mit März 2020.
The PhD studies provide an in-depth, multidisciplinary training in biomedical research in a stimulating international environment. The thesis projects focus on aspects of metabolic and cardiovascular diseases, cancer, lipids and metabolism as novel therapeutic targets and diagnostic methods, and integrate basic research and clinically-oriented sciences utilizing a wide spectrum of state-of-the-art techniques.
Selected PhD students get employed for up to 3 years (initial contract for one year with the option of prolongation upon successful performance) with a contract that includes social benefits. Moreover, students in the DK-MCD and the SFB Lipid Hydrolysis will be encouraged to spend up to one year abroad joining other collaborating laboratories with the possibility of a 4th year extension of their contract.
Applicants must hold (or be close to obtaining) an undergraduate degree equivalent to a Master in any discipline of natural or life sciences or medicine. The selection procedure, all training activities and communications will be in English. Thus, excellent written and spoken English skills are required.
Applications are exclusively accepted through the online platform https://mug.glowbase.com/. Please refrain from contacting the supervisors and do not send any documents by regular mail or e-mail unless you are explicitly asked to do so by our staff. There is no application fee.
For further information about the programs, open projects and the online application procedure, please see: http://www.medunigraz.at/DK_MCD/Call.htm